Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
ESHO 2024
Programm
Personen
Suche
DE
Zurück
Scientific session
Session 4
Superficial hyperthermia
Termin
Datum:
07.11.2024
Zeit:
11:00
–
12:30
Ort / Stream:
Aula 5
Chair
Dr. Ignacio Toscas
Barcelona / ES
Dr. Emanuel Stutz
Bern / CH
Programm
11:00
–
11:20
15 Min.
5 Min.
Invited Talk
IT-04
The potential of wIRA-hyperthermia in extended superficial tumors
Dr. Marcus Notter (Bern / CH)
11:20
–
11:32
9 Min.
3 Min.
Oral Presentation
OP-15
Background, study design and treatment protocol of the upcoming TANCA-I trial: Thermoradiotherapy for locally advanced head and neck cancer patients-a phase I trial
Dr. Michiel Kroesen (Rotterdam / NL)
Ongoing clinical trials
11:32
–
11:44
9 Min.
3 Min.
Oral Presentation
OP-16
Multimodality therapy for high-risk soft tissue sarcomas of the trunk and limbs: evaluation of toxicity, efficacy and long-term outcomes of hyperthermia in combination with preoperative radiotherapy and chemotherapy
Dr. Pasquale Trecca (Rome / IT)
Ongoing clinical trials
11:44
–
11:56
9 Min.
3 Min.
Oral Presentation
OP-17
The predictive value of hyperthermia temperature parameters for locoregional control in patients with locoregional recurrent breast cancer treated with postoperative re-irradiation and hyperthermia: An evaluation of invasive versus skin thermometry
Drs. C. Paola Tello Valverde (Amsterdam / NL)
Ongoing clinical trials
11:56
–
12:08
9 Min.
3 Min.
Oral Presentation
OP-18
Impact of uncertainties in the delivery of microwave hyperthermia treatments for head and neck cancer
Dr. Massimiliano Zanoli (Rotterdam / NL)
Q&A: thermometry, treatment planning, image guide
12:08
–
12:20
9 Min.
3 Min.
Oral Presentation
OP-19
The HISTOTHERM study: wIRA-hyperthermia and hypofractionated radiation therapy for locally recurrent breast cancer – preliminary results
Dr. Andreas R. Thomsen (Freiburg / DE)
Ongoing clinical trials
12:20
–
12:22
2 Min.
0 Min.
Flash Presentation
FP-15
First measurements with a phantom for infrared hyperthermia devices according to ESHO guidelines
Dietmar Marder (Aarau / CH)
Q&A: thermometry, treatment planning, image guide
12:22
–
12:24
2 Min.
0 Min.
Flash Presentation
FP-16
Reirradiation and hyperthermia in patients with recurrent previously irradiated angiosarcoma in head and neck
Tatiana Lushchaeva (Magdeburg / DE)
Hyperthermia clinical applications: radio-chemo-immunotherapy
12:24
–
12:26
2 Min.
0 Min.
Flash Presentation
FP-17
Characterization of 434 MHz CFMA applicators for superficial hyperthermia for various realistic curvature and bolus thickness scenarios
Timoteo Daniel Herrera (Amsterdam / NL)
Q&A: thermometry, treatment planning, image guide
12:26
–
12:28
2 Min.
0 Min.
Flash Presentation
FP-18
Fast tumor volume reduction in fungating bulky breast cancer following combined palliative radiotherapy and hyperthermia: Case reports of two patients
Dr. Emanuel Stutz (Bern / CH)
Hyperthermia clinical applications: radio-chemo-immunotherapy
12:28
–
12:30
2 Min.
0 Min.
Flash Presentation
FP-19
Impact of Schottky diodes feeding traces on E-field characterization of 434MHz hyperthermia applicators
Deovrat Phal (Eindhoven / NL)
Q&A: thermometry, treatment planning, image guide
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz